{"news_desk": "Science", "print_page": "1", "subsection_name": null, "section_name": "Health", "byline": {"contributor": "", "original": "By DENISE GRADY", "person": [{"firstname": "Denise", "rank": 1, "lastname": "GRADY", "organization": "", "role": "reported"}]}, "abstract": null, "type_of_material": "News", "word_count": "2250", "keywords": [{"rank": "1", "value": "Cancer", "is_major": "N", "name": "subject"}, {"rank": "2", "value": "Clinical Trials", "is_major": "N", "name": "subject"}, {"rank": "3", "value": "Minorities", "is_major": "N", "name": "subject"}, {"rank": "4", "value": "Blacks", "is_major": "N", "name": "subject"}, {"rank": "5", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "name": "subject"}], "lead_paragraph": "As immunotherapy research takes off, the patients getting the treatment have been overwhelmingly white. Researchers know this and say they are trying to correct it.", "pub_date": "2016-12-23T10:01:27+0000", "document_type": "article", "source": "The New York Times", "snippet": "As immunotherapy research takes off, the patients getting the treatment have been overwhelmingly white. Researchers know this and say they are trying to correct it....", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wide": "images/2016/12/21/science/28CANCER2/28CANCER2-thumbWide.jpg", "wideheight": "126"}, "type": "image", "width": 190, "url": "images/2016/12/21/science/28CANCER2/28CANCER2-thumbWide.jpg"}, {"height": 400, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2016/12/21/science/28CANCER2/28CANCER2-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2016/12/21/science/28CANCER2/28CANCER2-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/12/21/science/28CANCER2/28CANCER2-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "url": "images/2016/12/21/science/28CANCER2/28CANCER2-thumbStandard.jpg"}], "web_url": "http://www.nytimes.com/2016/12/23/health/cancer-trials-immunotherapy.html", "slideshow_credits": null, "blog": [], "_id": "585cf5fc95d0e03926077861", "headline": {"main": "In Cancer Trials, Minorities Face Extra Hurdles", "print_headline": "Minorities Face Extra Hurdles in Cancer Trials"}}